The analysis of 42 human cytomegalovirus-positive (HCMV-positive) GBM patients revealed that CD57+CD28−CD4 T cells are expanded and associated with poor prognosis [50], thus pointing out immunosenescence as a relevant pathway to boost T cell response in GBM. This evidence concerns the gene B3GAT1 and glioblastoma.